A pharmaceutical company was looking to acquire an asset in the Hormone-Sensitive Prostate Cancer space.
Understanding Prostate Cancer, its stages and occurrence of HSPC in disease progression
Literature search for treatment guidelines and current treatment options in HSPC space.
Scanning public sources, company releases and proprietary datasets to understand active clinical pipeline.
Highlighting top prospects for acquisition based on clinical profile of the products and analysis of manufacturer.
Aspect Ratio has experience across therapy areas like Oncology, Immunology, Infectious Diseases, Neurosciences, Rare Diseases among others.
Let’s open a conversation on how Aspect Ratio can give your organization a competitive edge.
